Similar Articles
Systemic Scleroderma in Childhood: A Case Report
Aslı ASLAN, Güldane KOTUROĞLU, Betül SÖZERİ, Zafer KURUGÖL
DOI: 10.5606/ArchRheumatol.2014.3684
Serum Interleukin-18 Level is Associated With Disease Activity and Interstitial Lung Disease in Patients With Dermatomyositis
Yuan YANG, Geng YIN, Jingcheng HAO, Qibing XIE, Yi LIU
DOI: 10.5606/ArchRheumatol.2017.6175
The Association of Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibodies in Patients With Rheumatoid Arthritis and Interstitial Lung Disease
Masakazu MATSUSHITA, Naoto TAMURA, Michihiro OGASAWARA, Kurisu TADA, Ken YAMAJI, Yoshinari TAKASAKI
DOI: 10.5606/ArchRheumatol.2018.6401
Value of Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Evaluating Severity and Prognosis of Connective Tissue Disease-Associated Interstitial Lung Disease
Qian JIN, Jisheng ZHENG, Xianrong XU, Yeming HU, Ying ZHOU, Weihua XU, Feihua HUANG
DOI: 10.5606/ArchRheumatol.2018.6419
Clinical Characteristics of Systemic Sclerosis With Interstitial Lung Disease
Eunju JUNG, Chang-hee SUH, Hyoun-ah KİM, Ju-yang JUNG
DOI: 10.5606/ArchRheumatol.2018.6630
Juvenile Scleroderma: A Referral Center Experience
Amra ADROVIC, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR
DOI: 10.5606/ArchRheumatol.2018.6578
Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy?
Gökhan SARGIN, Reyhan KÖSE, Taşkın ŞENTÜRK
DOI: 10.5606/ArchRheumatol.2018.6691
Efficacy of Combination Therapy With Pirfenidone and Low-Dose Cyclophosphamide for Refractory Interstitial Lung Disease Associated With Connective Tissue Disease: A Case-Series of Seven Patients
Lichong SHEN, Qingran YAN, Xiaoxiang CHEN
DOI: 10.46497/ArchRheumatol.2020.7381
Mixed Connective Tissue Disease With Retroperitoneal Fibrosis: A Rare Occurrence
Aditya DHANAWAT, Partisha GUPTA, Prasanta PADHAN
DOI: 10.5606/ArchRheumatol.2020.7452
Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus
Yaling CHEN, Yanqing WANG, Xiangfang CHEN, Huishun LIANG, Xuwei YANG
DOI: 10.46497/ArchRheumatol.2020.7583
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases
Andreina MANFREDI, Giulia CASSONE, Caterina VACCHI, Fabrizio PANCALDI, Giovanni Della CASA, Stefania CERRI, Lisa De PASQUALE, Fabrizio LUPPI, Carlo SALVARANI, Marco SEBASTIANI
DOI: 10.46497/ArchRheumatol.2021.7975
SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center
Betül Sözeri, Ferhat Demir, Sevinç Kalın, Canan Hasbal Akkuş, Enes Salı, Deniz Çakır
DOI: 10.46497/ArchRheumatol.2021.8603
Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan
Sadia Asif, Asadullah Khan, Muhammad Faiq, Zia Ud Din, Sarmad Zahoor, Muhammad Haroon
DOI: 10.46497/ArchRheumatol.2021.8701
Is COVID-19 multisystem inflammatory syndrome a new variant of Kawasaki Disease?
Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Tasnim Dawoud, Walid Abu Hammour
DOI: 10.46497/ArchRheumatol.2022.9086
How do COVID-19 vaccines affect rheumatic diseases?
Lale Altan, Salim Mısırcı, İlker Yağcı, Meltem Karacaatlı, Feyza Ünlü Özkan, Altuğ Güner, İlknur Aktaş
DOI: 10.46497/ArchRheumatol.2023.9530
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2023.10199
Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases
Fatih Taştekin, Meltem Taşbakan, Candan Çiçek, Mehmet Soylu, Figen Yargucu Zihni
DOI: 10.46497/ArchRheumatol.2023.9676
Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study
Jakob Höppner, Maximilian Wollsching-Strobel, Falk Schumacher, Wolfram Windisch, Melanie Berger
DOI: 10.46497/ArchRheumatol.2024.10105